I en ytterligare randomiserad klinisk prövning (M77001) erhöll patienter med metastaserad bröstcancer docetaxel, med eller utan Herceptin. ###>In a further randomised clinical trial (M77001), patients with metastatic breast cancer received docetaxel, with or without Herceptin.